24 Jul
Hadassah Cancer Research Institute (HCRI), a leading force in advancing cancer treatments, unveils a significant breakthrough in personalised cancer care. This research, published in the esteemed journal Cell Reports Medicine (June 11, 2024), introduces MESiCA, a novel machine learning model poised to revolutionise cancer diagnosis and treatment. Professor Michal Lotem, Head of HCRI […]
READ MORE8 Mar
Hadassah Cancer Research Institute at the Hadassah University Hospital in Jerusalem, announced last month that researchers have designed a genomic analysis tool for cancer patients that enables advanced selection of drugs targeting schemes for cancer genes, opening the door to improved personalised medicine in cancer treatment. The science behind this breakthrough tool is a […]
READ MOREHadassah UK © 2022 | w/creators with Web Studio Lab
Join our digital newsletter to stay in touch with the latest news from Hadassah UK